Early Decision Making in a Randomized Phase II Trial of Atezolizumab in Biliary Tract Cancer Using a Tumor Growth Inhibition-Survival Modeling Framework

We assess the longitudinal tumor growth inhibition (TGI) metrics and overall survival (OS) predictions applied to patients with advanced biliary tract cancer (BTC) enrolled in IMbrave151 a multicenter randomized phase II, double-blind, placebo-controlled trial evaluating the efficacy and safety of a...

Full description

Saved in:

Bibliographic Details
Published in:	Clinical pharmacology and therapeutics Vol. 114; no. 3; p. 644
Main Authors:	Shemesh, Colby S, Chan, Phyllis, Marchand, Mathilde, Gonçalves, Antonio, Vadhavkar, Shweta, Wu, Benjamin, Li, Chunze, Jin, Jin Y, Hack, Stephen P, Bruno, Rene
Format:	Journal Article
Language:	English
Published:	United States 01.09.2023
ISSN:	1532-6535, 1532-6535
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!